Autopsy report · NCT01179399
Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 2 years 4 months before it stopped.
- 32 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Sponsor type
- Industry
- Conditions
- Advanced Nonhematological Malignancies
- Interventions
- TAK-960
- Participants
- 32
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.